Search Results - "Remacle, A G"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Furin regulates the intracellular activation and the uptake rate of cell surface-associated MT1-MMP by REMADE, A. G, ROZANOV, D. V, FUGERE, M, DAY, R, STRONGIN, A. Y

    Published in Oncogene (14-09-2006)
    “…Invasion-promoting membrane type-1 matrix metalloproteinase (MT1-MMP) functions in cancer cells as an oncogene and as a mediator of proteolytic events on the…”
    Get full text
    Journal Article
  2. 2

    Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer by REMACLE, A. G, NOËL, A, DUGGAN, C, MCDERMOTT, E, O'HIGGINS, N, FOIDART, J. M, DUFFY, M. J

    Published in British journal of cancer (01-03-1998)
    “…Matrix metalloproteinases (MMPs) are zinc dependent endopeptidases implicated in cancer invasion and metastasis. Gelatin zymography was performed on 84 human…”
    Get full text
    Journal Article Web Resource
  3. 3

    A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14/MT1–MMP by Shiryaev, S A, Remacle, A G, Golubkov, V S, Ingvarsen, S, Porse, A, Behrendt, N, Cieplak, P, Strongin, A Y

    Published in Oncogenesis (New York, NY) (01-12-2013)
    “…Matrix metalloproteinases (MMPs) and, especially membrane type 1 (MT1)-MMP/MMP-14, are promising drug targets in malignancies. In contrast with multiple…”
    Get full text
    Journal Article
  4. 4

    Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase by Emonard, H P, Remacle, A G, Noël, A C, Grimaud, J A, Stetler-Stevenson, W G, Foidart, J M

    Published in Cancer research (Chicago, Ill.) (15-10-1992)
    “…We have studied the capacity of two human breast adenocarcinoma cells, MDA-MB231 and MCF-7, to bind exogenous M(r) 72,000 type IV collagenase by both…”
    Get full text
    Journal Article Web Resource
  5. 5

    Expression of Concern: Distinct Interactions with Cellular E-Cadherin of the Two Virulent Metalloproteinases Encoded by a Bacteroides fragilis Pathogenicity Island

    Published in PloS one (06-06-2022)
    “…[...]of these inactivating mutations, Ala substitutes for the essential active site Glu residue. The FRA3 and FRA3-E349A panels in Fig 5B are redacted as they…”
    Get full text
    Journal Article
  6. 6

    Timp‐2 binding with cellular MT1‐MMP stimulates invasion‐promoting MEK/ERK signaling in cancer cells by Sounni, Nor Eddine, Rozanov, Dmitri V., Remacle, Albert G., Golubkov, Vladislav S., Noel, Agnes, Strongin, Alex Y.

    Published in International journal of cancer (01-03-2010)
    “…Both invasion‐promoting MT1‐MMP and its physiological inhibitorTIMP‐2 play a significant role in tumorigenesis and are identified in the most aggressive…”
    Get full text
    Journal Article Web Resource
  7. 7

    Purification of Progelatinases A and B by Continuous-Elution Electrophoresis by Remacle, A.G., Baramova, E.N., Weidle, U.H., Krell, H.W., Foidart, J.M.

    Published in Protein expression and purification (01-08-1995)
    “…Progelatinases A and B were purified from HT1080-conditioned culture medium using a continuous-elution electrophoresis. Initially cell culture medium was…”
    Get full text
    Journal Article Web Resource
  8. 8
  9. 9

    transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP) by Remacle, Albert G, Rozanov, Dmitri V, Baciu, Peter C, Chekanov, Alexei V, Golubkov, Vladislav S, Strongin, Alex Y

    Published in Journal of cell science (01-11-2005)
    “…Membrane type-1 matrix metalloproteinase (MT1-MMP) degrades the extracellular matrix, initiates the activation pathway of soluble MMPs and regulates the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Tumor cell surface-associated binding site for the M sub(r) 72,000 type IV collagenase by Emonard, H P, Remacle, A G, Noel, A C, Grimaud, J-A, Stetler-Stevenson, W G, Foidart, J-M

    Published in Cancer research (Chicago, Ill.) (01-01-1992)
    “…We have studied the capacity of two human breast adenocarcinoma cells, MDA-MB231 and MCF-7, to bind exogenous M sub(r) 72,000 type IV collagenase by both…”
    Get full text
    Journal Article